皓元医药(688131.SH)：拟使用不超5亿元的闲置募集资金进行现金管理

Group 1 - The company, Haoyuan Pharmaceutical (688131.SH), announced plans to utilize up to RMB 500 million of idle raised funds for cash management [1] - The usage period for these funds is effective for 12 months from the date of approval by the board of directors [1] - Within the specified limit and timeframe, the funds can be used in a rolling manner [1]